OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
221056

Nama Chemicals Company SJSC

Commodity ChemicalsVerified

NAMA's capital structure is highly leveraged, with a debt-to-equity ratio of 2.3, indicating significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.29, suggesting limited ability to meet short-term obligations. Despite a negative operating cash flow of -33.844 million SAR, NAMA generated 62.547 million SAR in free cash flow, which may be attributed to non-cash adjustments or asset sales. Profitability metrics show mixed results. NAMA reported a net income of 11.719 million SAR but experienced a gross loss of 65.597 million SAR, indicating cost overruns or declining margins. Return on equity (ROE) was 4.8%, and return on assets (ROA) was 1.07%, both below the typical thresholds for the Commodity Chemicals industry, which is known for low-margin operations. NAMA's revenue is concentrated within its core chemical production segments, with no disclosed geographic diversification in the provided data. The company operates through subsidiaries in Saudi Arabia and Germany, but the financial snapshot does not provide segment-specific revenue breakdowns. Growth trajectory appears constrained. NAMA's revenue for the latest period was 380.301 million SAR, but the company reported a gross loss, suggesting operational inefficiencies or declining demand. The outlook for the current and next fiscal years is not explicitly provided, but the negative gross profit and weak liquidity position raise concerns about near-term growth. Risk factors include medium liquidity risk due to a weak current ratio and negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the company's high leverage and negative operating cash flow could increase financial risk in the event of rising interest rates or declining revenues. Recent events include the latest financial filing, which disclosed a negative gross profit and weak operating cash flow. No recent transcripts or filings beyond the financial snapshot are provided in the input data.

30-day price · 2210-1.41 (-7.0%)
Low$18.56High$20.68Close$18.74As of21 May, 00:00 UTC
Profile
CompanyNama Chemicals Company SJSC
Ticker2210.SE
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. NAMA Chemicals Company SJSC (NAMA) is a Saudi Arabia-based company engaged in developing, owning, operating and managing industrial projects in the petrochemical and chemical fields, producing products such as epoxy, caustic soda, epichlorohydrin, calcium chloride, hydrochloric acid, and sodium hypochlorite.

Classification. NAMA is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

NAMA's capital structure is highly leveraged, with a debt-to-equity ratio of 2.3, indicating significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.29, suggesting limited ability to meet short-term obligations. Despite a negative operating cash flow of -33.844 million SAR, NAMA generated 62.547 million SAR in free cash flow, which may be attributed to non-cash adjustments or asset sales. Profitability metrics show mixed results. NAMA reported a net income of 11.719 million SAR but experienced a gross loss of 65.597 million SAR, indicating cost overruns or declining margins. Return on equity (ROE) was 4.8%, and return on assets (ROA) was 1.07%, both below the typical thresholds for the Commodity Chemicals industry, which is known for low-margin operations. NAMA's revenue is concentrated within its core chemical production segments, with no disclosed geographic diversification in the provided data. The company operates through subsidiaries in Saudi Arabia and Germany, but the financial snapshot does not provide segment-specific revenue breakdowns. Growth trajectory appears constrained. NAMA's revenue for the latest period was 380.301 million SAR, but the company reported a gross loss, suggesting operational inefficiencies or declining demand. The outlook for the current and next fiscal years is not explicitly provided, but the negative gross profit and weak liquidity position raise concerns about near-term growth. Risk factors include medium liquidity risk due to a weak current ratio and negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the company's high leverage and negative operating cash flow could increase financial risk in the event of rising interest rates or declining revenues. Recent events include the latest financial filing, which disclosed a negative gross profit and weak operating cash flow. No recent transcripts or filings beyond the financial snapshot are provided in the input data.
Key takeaways
  • NAMA is highly leveraged with a debt-to-equity ratio of 2.3, indicating significant financial risk.
  • The company reported a gross loss of 65.597 million SAR, suggesting operational inefficiencies or declining margins.
  • Free cash flow of 62.547 million SAR contrasts with a negative operating cash flow, indicating potential non-cash adjustments or asset sales.
  • Liquidity is weak, with a current ratio of 0.29 and negative net cash after subtracting total debt.
  • The company's profitability metrics (ROE of 4.8%, ROA of 1.07%) are below typical thresholds for the Commodity Chemicals industry.
  • No significant dilution risk is identified, but the company's financial position could deteriorate if operating cash flow remains negative.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$380.3M
Gross profit-$65.6M
Operating income$39.5M
Net income$11.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$33.8M
CapEx-$12.7M
Free cash flow$62.5M
Total assets$1.10B
Total liabilities$855.0M
Total equity$244.1M
Cash & equivalents
Long-term debt$561.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$244.1M
Net cash-$561.0M
Current ratio0.3
Debt/Equity2.3
ROA1.1%
ROE4.8%
Cash conversion-2.9%
CapEx/Revenue-3.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2210Activity
Op margin10.4%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin-17.2%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity230.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 14:02 UTC#a5a4738f
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 14:05 UTCJob: 145370b7